AlphaCentric Advisors »

Myomo shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Myomo (MYO) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Myomo

Tip: Access up to 7 years of quarterly data

All positions including Myomo held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myomo by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $201k 50k 4.01

More positions owned by AlphaCentric Advisors

Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
Galapagos Nv Spon Adr (GLPG)
Merck & Co (MRK)
Ellington Financial Inc ellington financ (EFC)
Neurocrine Biosciences (NBIX)
MGIC Investment (MTG)
Argenx Se Sponsored Adr (ARGX)
Indivior Ord (INDV)
Dynex Cap (DX)
BioMarin Pharmaceutical (BMRN)
Sarepta Therapeutics (SRPT)
Dynavax Technologies Corp Com New (DVAX)
United Therapeutics Corporation (UTHR)
Redwood Trust (RWT)

View all positions for AlphaCentric Advisors

Top funds holding Myomo

Rosalind Advisors
AIGH Capital Management
Herr Investment Group
Vanguard Group
Essex Investment Management
Geode Capital Management
Legato Capital Management
BlackRock
Renaissance Technologies
State Street Corporation
GSA Capital Partners
Bridgeway Capital Management
AlphaCentric Advisors
Stratos Wealth Partners
Accel Wealth Management

View all funds holding Myomo